Amgen Inc. ( AMGN ) will begin trading ex-dividend on February 14, 2019. A cash dividend payment of $1.45 per share is scheduled to be paid on March 08, 2019. Shareholders who purchased AMGN prior to the ex-dividend date are eligible for the cash dividend payment. This represents an 9.85% increase over prior dividend payment.
The previous trading day's last sale of AMGN was $188.43, representing a -10.35% decrease from the 52 week high of $210.19 and a 15.38% increase over the 52 week low of $163.31.
AMGN is a part of the Health Care sector, which includes companies such as Gilead Sciences, Inc. ( GILD ) and Biogen Inc. ( BIIB ). AMGN's current earnings per share, an indicator of a company's profitability, is $12.6. Zacks Investment Research reports AMGN's forecasted earnings growth in 2019 as -3.27%, compared to an industry average of 9.1%.
Interested in gaining exposure to AMGN through an Exchange Traded Fund [ETF]?
The following ETF(s) have AMGN as a top-10 holding:
- VanEck Vectors Biotech ETF ( BBH )
- iShares Nasdaq Biotechnology Index Fund ( IBB )
- Invesco Dynamic Pharmaceuticals ETF ( PJP )
- Invesco Dynamic Biotech & Genome ETF ( PBE )
- Invesco BuyBack Achievers ETF ( PKW ).
The top-performing ETF of this group is BBH with an decrease of -3.77% over the last 100 days. It also has the highest percent weighting of AMGN at 8.18%.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of NASDAQ, Inc.